Streptococcus pneumoniae serotype 15A in psychiatric unit, Rhode Island, USA, 2010-2011

Emerging Infectious Diseases

Volumn 18, Issue 11, 2012, Pages 1889-1893

  Fleming Dutra, Katherine ^a   Mbaeyi, Chukwuma ^a   Link Gelles, Ruth ^a   Alexander, Nicole ^b,c   Guh, Alice ^a   Forbes, Elizabeth ^c   Beall, Bernard ^a   Winchell, Jonas M ^a   Carvalho, Maria da Gloria ^a   Pimenta, Fabiana ^a   Kodani, Maja ^a   Vanner, Cindy ^b   Stevens, Hilary ^a   Brady, Diane ^b   Caulcrick Grimes, Mardea ^b   Bandy, Utpala ^b   Moore, Matthew R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b RHODE ISLAND DEPARTMENT OF HEALTH   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; DOXYCYCLINE; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE TRANSMISSION; DRUG MEGADOSE; FEMALE; HOSPITAL INFECTION; HUMAN; HYGIENE; MALE; MYCOPLASMA PNEUMONIAE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PSYCHIATRIC DEPARTMENT; RHINOVIRUS; RISK FACTOR; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; THORAX RADIOGRAPHY; TREATMENT OUTCOME; UNITED STATES;

CROSS INFECTION; DISEASE OUTBREAKS; HOSPITAL UNITS; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; RHODE ISLAND; RISK FACTORS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84867857097     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1811.120454     Document Type: Article

References (16)

1. Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, Moore MR, et al. Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine. 2011;29:3398-412. http://dx.doi.org/10.1016/j. vaccine.2011.02.088
2. Basarab M, Ihekweazu C, George R, Pebody R. Effective management in clusters of pneumococcal disease: a systematic review. Lancet Infect Dis. 2011;11:119-30. http://dx.doi.org/10.1016/S1473-3099(10)70281-4
3. Centers for Disease Control and Prevention. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010;59:1102-6.
4. Nuorti JP, Whitney CG. Prevention of pneumococcal disease among infants and children-use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59(RR-11):1-18. PMID: 21150868
5. O'Brien KL, Bronsdon MA, Dagan R, Yagupsky P, Janco J, Elliott J, et al. Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol. 2001;39:1021-
6. http://dx.doi.org/10.1128/JCM.39.3.1021-1024.2001
7. da Gloria Carvalho M, Pimenta FC, Jackson D, Roundtree A, Ahmad Y, Millar EV, et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol. 2010;48:1611-8. http://dx.doi.org/10.1128/JCM.02243-09
8. Pai R, Gertz RE, Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol. 2006;44:124-31. http://dx.doi.org/10.1128/JCM.44.1.124-131.2006
9. Centers for Disease Control and Prevention. PCR deduction of pneumococcal serotypes [cited 2011 Jan 29]. http://www.cdc.gov/ncidod/biotech/strep/PCR.htm
10. Multi locus sequence typing. Streptococcus pneumoniae. [cited 2011 Jan 29]. http://spneumoniae.mlst.net/
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first information supplement. Wayne (PA): The Institute; 2011.
12. Kodani M, Yang G, Conklin L, Travis T, Whitney C, Anderson L, et al. Application of TaqMan low-density arrays for simultaneous detection of multiple respiratory pathogens. J Clin Microbiol. 2011;49:2175-82. http://dx.doi.org/10.1128/JCM.02270-10
13. Peltola VT, McCullers JA. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr Infect Dis J. 2004;23(Suppl):S87-97. http://dx.doi.org/10.1097/01. inf.0000108197.81270.35
14. Sá-Leão R, Nunes S, Brito-Avo A, Frazao N, Simoes AS, Crisostomo MI, et al. Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect. 2009;15:1002-7. http://dx.doi.org/10.1111/j.1469-0691.2009.02775.x
15. Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124:e1-11. http://dx.doi.org/10.1542/peds.2008-3099
16. Gertz RE Jr, Li Z, Pimenta FC, Jackson D, Juni BA, Lynfield R, et al. Increased penicillin nonsusceptibility of nonvaccine-serotype invasive pneumococci other than serotypes 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis. 2010;201:770-5. http://dx.doi. org/10.1086/650496